Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Alcohol Drinking

ribavirin has been researched along with Alcohol Drinking in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (65.00)29.6817
2010's7 (35.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bair, MJ; Chen, HL; Chen, MJ; Lin, CC; Lin, IT; Shih, SC; Wang, HY; Wang, TE; Wu, CH1
Blanco, Cdel V; Federico, A; Loguercio, C; Masarone, M; Persico, M; Torella, R1
Parkinson, E1
Bruggmann, P; Dampz, M; Falcato, L; Gerlach, T; Kravecz, L1
Ghany, MG; Seeff, LB1
Crouzet, J; Di Martino, V; Hillon, P; Minello, A; Monnet, E; Thévenot, T1
Chawla, YK; Das, A; Dhiman, RK; Duseja, A; Ghosh, S; Sharma, BK; Taneja, S; Tohra, SK1
Alcaide, N; Aller, R; Almansa, R; Bermejo-Martín, JF; Caro-Patón, A; de la Fuente, C; González, JM; Jiménez-Sousa, MÁ; Largo, P; Ortiz de Lejarazu, R; Ruiz, L; Sánchez-Antolín, G1
Chia, C; Cunanan, RJ; Dorrell, J; Martin, S; Moore, CD; Pauly, MP; Russell, M; Witt, G1
Folwaczny, C; Grunze, H; Heldwein, W; Koenig, A; Loeschke, K; Lorenz, R; Martin, G; Schaefer, M; Schindlbeck, N; Schmidt, F; Soyka, M1
Black, M; Chang, A; Friedenberg, FK; Gautam, M; Horwitz, B; Schmutz, J; Skole, K; Thomas, R1
Anand, BS; Bini, EJ; Currie, S; Dieperink, E; Ho, SB; Shen, H; Wright, T1
de los Santos Gil, I; González Cerrajero, M; Pazos García, A; Sanz Sanz, J1
Duggan, AE; Duggan, JM1
Bassett, ML1
Adachi, Y; Araki, J; Fujita, N; Horiike, S; Iwasa, M; Kaito, M; Kobayashi, Y; Mifuji, R; Sugimoto, R; Tanaka, H; Urawa, N; Yamamoto, M1
Cacoub, P; Saadoun, D; Sène, D1
Ammassari, A; Giuliani, M; Lacaita, MG; Lajolo, C; Sartorio, A; Scivetti, M; Tamburrini, E; Tumbarello, M1
Gebo, K1

Reviews

3 review(s) available for ribavirin and Alcohol Drinking

ArticleYear
Management of untreated and nonresponder patients with chronic hepatitis C.
    Seminars in liver disease, 2010, Volume: 30, Issue:4

    Topics: Alcohol Drinking; Antiviral Agents; Biopsy; Decision Making; Deoxycytidine; Disease Management; Disease Progression; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Obesity; Polyethylene Glycols; Practice Patterns, Physicians'; Recombinant Proteins; Retreatment; Ribavirin; RNA, Viral; Treatment Failure; Viral Load; Virus Replication

2010
[Treatment of hepatitis C. Consensus conference].
    Presse medicale (Paris, France : 1983), 2002, Jun-15, Volume: 31, Issue:21 Pt 1

    Topics: Alcohol Drinking; Antiviral Agents; Drug Administration Schedule; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Patient Selection; Ribavirin; Severity of Illness Index

2002
[Cryoglobulinemia].
    La Revue de medecine interne, 2008, Volume: 29, Issue:3

    Topics: Alcohol Drinking; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Fatty Liver; Female; Hepatitis C; Humans; Immunologic Factors; Interferon-alpha; Liver Cirrhosis; Male; Recurrence; Ribavirin; Rituximab; Sex Factors; Vasculitis

2008

Trials

2 trial(s) available for ribavirin and Alcohol Drinking

ArticleYear
The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    The American journal of gastroenterology, 2008, Volume: 103, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Antiviral Agents; Diet; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Ribavirin; Young Adult

2008
Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.
    Journal of gastroenterology and hepatology, 2007, Volume: 22, Issue:11

    Topics: Adult; Aged; Alcohol Drinking; Antiviral Agents; Disease Progression; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Iron; Iron Overload; Liver; Male; Middle Aged; Platelet Count; Recombinant Proteins; Ribavirin; Risk Factors; Severity of Illness Index; Sex Factors; Transaminases; Treatment Outcome

2007

Other Studies

15 other study(ies) available for ribavirin and Alcohol Drinking

ArticleYear
Hepatitis C treatment outcome in relation to alcohol consumption and racial differences in southeastern Taiwan.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2015, Volume: 114, Issue:11

    Topics: Adult; Aged; Alcohol Drinking; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; Taiwan; Treatment Outcome; Viral Load

2015
What now? Responding to relapse in hepatitis C.
    Advance for nurse practitioners, 2007, Volume: 15, Issue:12

    Topics: Alcohol Drinking; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Male; Nurse Practitioners; Patient Education as Topic; Polyethylene Glycols; Primary Health Care; Recombinant Proteins; Recurrence; Referral and Consultation; Ribavirin; Risk Factors; United States; Viral Load

2007
Treatment outcome in relation to alcohol consumption during hepatitis C therapy: an analysis of the Swiss Hepatitis C Cohort Study.
    Drug and alcohol dependence, 2010, Jul-01, Volume: 110, Issue:1-2

    Topics: Adult; Alcohol Drinking; Antiviral Agents; Cohort Studies; Female; Hepatitis C, Chronic; Humans; Interferon Type I; Liver Cirrhosis; Male; Middle Aged; Patient Compliance; Recombinant Proteins; Regression Analysis; Retrospective Studies; Ribavirin; RNA, Viral; Socioeconomic Factors; Switzerland; Treatment Outcome; Viral Load

2010
Long-term outcome of chronic hepatitis C in a population-based cohort and impact of antiviral therapy: a propensity-adjusted analysis.
    Journal of viral hepatitis, 2011, Volume: 18, Issue:7

    Topics: Adolescent; Adult; Aged; Alcohol Drinking; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome

2011
Prediction of sustained virological response to combination therapy with pegylated interferon alfa and ribavirin in patients with genotype 3 chronic hepatitis C.
    Digestive diseases and sciences, 2011, Volume: 56, Issue:8

    Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Alcohol Drinking; Antiviral Agents; Body Mass Index; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome; Young Adult

2011
[Gene expression profiling in the first twelve weeks of treatment in chronic hepatitis C patients].
    Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29, Issue:8

    Topics: Adult; Alcohol Drinking; Antiviral Agents; Drug Therapy, Combination; Female; Gene Expression Profiling; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Time Factors; Viremia

2011
The impact of lifetime alcohol use on hepatitis C treatment outcomes in privately insured members of an integrated health care plan.
    Hepatology (Baltimore, Md.), 2012, Volume: 56, Issue:4

    Topics: Adult; Aged; Alcohol Drinking; Antiviral Agents; California; Cohort Studies; Confidence Intervals; Delivery of Health Care, Integrated; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Insurance, Health; Interferon-alpha; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polyethylene Glycols; Private Sector; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome

2012
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:2

    Topics: Adult; Alcohol Drinking; Antidepressive Agents; Antiviral Agents; Depression; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Medical Records; Mental Disorders; Methadone; Middle Aged; Patient Compliance; Patient Dropouts; Prospective Studies; Ribavirin; Risk Factors; Substance-Related Disorders

2003
The impact of past alcohol use on treatment response rates in patients with chronic hepatitis C.
    Alimentary pharmacology & therapeutics, 2005, Oct-15, Volume: 22, Issue:8

    Topics: Adult; Alcohol Drinking; Antiviral Agents; Black People; Drug Therapy, Combination; Ethanol; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prognosis; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Failure; Treatment Outcome

2005
Alcohol use and treatment of hepatitis C virus: results of a national multicenter study.
    Gastroenterology, 2006, Volume: 130, Issue:6

    Topics: Aged; Alcohol Drinking; Antiviral Agents; Case-Control Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Male; Middle Aged; Patient Selection; Probability; Prospective Studies; Recombinant Proteins; Reference Values; Ribavirin; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Survival Rate; Treatment Outcome

2006
[Prevalence of hepatitis C virus among HIV-infected patients in Area 2 of Madrid].
    Anales de medicina interna (Madrid, Spain : 1984), 2006, Volume: 23, Issue:3

    Topics: Adult; Alcohol Drinking; Antiviral Agents; CD4 Lymphocyte Count; Comorbidity; Cross-Sectional Studies; Drug Utilization; Female; Hepatitis C; HIV Infections; Humans; Interferons; Male; Middle Aged; Outpatients; Prevalence; Ribavirin; Risk Factors; Seroepidemiologic Studies; Sexual Behavior; Spain; Substance Abuse, Intravenous; Surveys and Questionnaires; Urban Population; Viral Load

2006
Peginterferon and ribavirin for hepatitis C.
    The New England journal of medicine, 2007, Mar-22, Volume: 356, Issue:12

    Topics: Alcohol Drinking; Antiviral Agents; Disease Progression; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2007
Iron and hepatitis C: beginning to make sense.
    Journal of gastroenterology and hepatology, 2007, Volume: 22, Issue:11

    Topics: Alcohol Drinking; Antiviral Agents; Disease Progression; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Iron; Iron Overload; Liver; Phlebotomy; Platelet Count; Recombinant Proteins; Ribavirin; Risk Factors; Severity of Illness Index; Sex Factors; Transaminases; Treatment Failure; Treatment Outcome

2007
Oral lesions in HIV and HCV co-infected individuals in HAART era.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2008, Volume: 37, Issue:8

    Topics: Adolescent; Adult; Aged; Alcohol Drinking; Antiretroviral Therapy, Highly Active; Antiviral Agents; Case-Control Studies; CD4 Lymphocyte Count; Coitus; Disease Susceptibility; Feeding Behavior; Female; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Mouth Diseases; Mouthwashes; Ribavirin; Risk Factors; Smoking; Substance Abuse, Intravenous; Time Factors; Viral Load; Young Adult

2008
HIV and hepatitis C.
    The Hopkins HIV report : a bimonthly newsletter for healthcare providers, 2002, Volume: 14, Issue:2

    Topics: Alcohol Drinking; Antiviral Agents; Hepatitis A Vaccines; Hepatitis C; Hepatitis C Antibodies; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Recombinant Proteins; Ribavirin

2002